RhoA Activation in Vascular Smooth Muscle Cells from Stroke-Prone Spontaneously Hypertensive Rats

Accession number;04A0398533
Title;RhoA Activation in Vascular Smooth Muscle Cells from Stroke-Prone Spontaneously Hypertensive Rats
Author; MORIKI N (Mie Univ. School Of Medicine, Tsu, Jpn) ITO M (Mie Univ. School Of Medicine, Tsu, Jpn) SEKO T (Mie Univ. School Of Medicine, Tsu, Jpn) KUREISHI Y (Mie Univ. School Of Medicine, Tsu, Jpn) OKAMOTO R (Mie Univ. School Of Medicine, Tsu, Jpn) NAKAKUKI T (Mie Univ. School Of Medicine, Tsu, Jpn) KONGO M (Mie Univ. School Of Medicine, Tsu, Jpn) ISAKA N (Mie Univ. School Of Medicine, Tsu, Jpn) KAIBUCHI K (Nagoya Univ., Nagoya, Jpn)
Journal Title;Hypertens Res
Journal Code:Y0303A
ISSN:0916-9636
VOL.27;NO.4;PAGE.263-270(2004)
Figure&Table&Reference;FIG.7, TBL.1, REF.44
Pub. Country;Japan
Language;English
Abstract;In order to clarify a part of molecular mechanism of the activation in the title, in vitro experiments such as immunological search methods were performed using vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats (SHRSP). As the result, the value of the activated RhoA in SHRSP was significantly larger than that in Wistar-Kyoto rats (WKY). There was no significant difference in the expression of RhoA/Rho kinase-related molecular group between SHRSP and WKY. Angiotensin 2 type I receptor antagonist decreased the activation of RhoA in SHRSP significantly and selectively. The expression of c-GMP dependent protein kinase I.ALPHA. (cGKI.ALPHA.) was lowered significantly in vascular smooth muscle cells of SHRSO. From the above, the possibility of decrease in expression of cGKI.ALPHA.and adjustment of autocrine/paracrine by angiotensin II was suggested as a molecular mechanism of the activation of Rhoa in vascular smooth muscle cells from SHRSP.
FULLTEXT